Alzheimer's disease: A firm base for drug development
暂无分享，去创建一个
[1] R. Barbour,et al. Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.
[2] Alfredo G. Tomasselli,et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.
[3] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[4] K. Beyreuther,et al. Mechanism of the cleavage specificity of Alzheimer's disease gamma-secretase identified by phenylalanine-scanning mutagenesis of the transmembrane domain of the amyloid precursor protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Drews. Genomic sciences and the medicine of tomorrow , 1996, Nature Biotechnology.
[6] D. Selkoe,et al. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide , 1993, Cell.
[7] R. Wang,et al. アミロイド前駆体蛋白質の貫通膜領域のフェニルアラニン‐走査突然変異誘発により確認されたアルツハイマー病γ‐セクレターゼの切断特異性の機序 , 1999 .
[8] D L Price,et al. Alzheimer's disease: genetic studies and transgenic models. , 1998, Annual review of genetics.